isoproterenol has been researched along with docetaxel anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Raymond, MN; Robin, P; Rossignol, B | 1 |
1 review(s) available for isoproterenol and docetaxel anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for isoproterenol and docetaxel anhydrous
| Article | Year |
|---|---|
Effect of microtubule network disturbance by nocodazole and docetaxel (Taxotere) on protein secretion in rat extraorbital lacrimal and parotid glands.
Topics: Animals; Bucladesine; Calcimycin; Carbachol; Docetaxel; Dose-Response Relationship, Drug; Epinephrine; Fluorescent Antibody Technique; Galactose; Glycoproteins; Isoproterenol; Lacrimal Apparatus; Male; Microtubules; Nocodazole; Paclitaxel; Parotid Gland; Phorbol 12,13-Dibutyrate; Rats; Rats, Sprague-Dawley; Taxoids | 1995 |